. . . . "526-36-3"@en . . . . "Xylometazoline is a direct acting sympathomimetic drug, which acts on alpha-adrenergic receptors in the arterioles of the nasal mucosa. This activates the adrenal system to yield systemic vasoconstrction. In producing vasoconstriction, the result is a decrease in blood flow in the nasal passages and consequently decreased nasal congestion. "@en . . "Xylometazoline"@en . . "It is used for treating nasal congestion and minor inflammation due to allergies or colds."@en . . . . "approved"@en . . . . . . "# Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, Bonisch H: Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam Clin Pharmacol. 2009 Dec 17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20030735 "@en . "A nasal vasoconstricting decongestant drug which acts by binding to the same receptors as adrenaline. It is applied as a spray or as drops into the nose to ease inflammation and congestion of the nasal passageways. It binds alpha-adrenergic receptors to activate the adrenal system which causes systemic vasoconstriction, thereby easing nasal congestion."@en . . . . . . . "Xylomethazoline"@en . . . . " "@en . "Balminil"@en . . . . . . . . . . . . . . . . . . . . .